Good to Great – Vision and Mission
Nayana Lab funds and grows good companies to be great. We empower teams with funding, methods and data to improve decision-making and outcomes. Ultimately, Nayana Lab will revolutionise the way data such as molecular interaction data is managed and used, by providing venture funding to good teams that have achieved results and want to become great.
We can intensively build your business with incubation and operating playbooks
Our team has delivered repeated success
Scientific and regulatory recruitment, clinical strategy, business development and financing are Nayana Lab fundamentals
We serve teams of scientists and entrepreneurs. Our core values are trust, integrity and respect for the dignity of others. We are experienced professionals in life sciences, analytics, business, medicine, science and finance. Your route from good to great will be tailormade for your business, orchestrating public and private equity and credit. And we are not afraid. If your business uses cells to produce medicines, managed by messenger RNA (mRNA) that moves DNA instructions to your cell’s protein making capability, please talk to us. You may be on the verge of transforming your niche, and we may be able to help. If your business disrupts – let’s prevent, treat and cure diseases together.
Our Story
Nayana Lab deeply understands the energy needed to form a wave, and recognises that energy before its effects emerge. We were founded to use technology to transform healthcare, by efficient capital deployment. Our journey is driven by passionate experts from the fields of healthcare, data science, and technology – and venture capital – who share a common goal of bridging the gap between good starting points and a desire to change a niche in the healthcare world.
Over time, we intend to grow our services to serve entities in molecular science, medical diagnosis, data extraction, imaging analysis, and mental health insights. Our commitment to innovation and excellence drives us to continuously improve our services, ensuring that we remain at the forefront of the health data venture industry.